Diabetes is a risk factor for high-dose methotrexate-associated AKI in lymphoma patients

Abstract

Patients with T2D have a higher sensitivity to AKI when administrated with HDMTX. This conclusion addresses safety concerns for making chemotherapy regimen for this population.